Lindsey Marie Hartley - 15 Dec 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role: CFO
Signature: /s/ Marc Began, as attorney-in-fact for Lindsey Hartley
Issuer symbol: AXGN
Transactions as of: 15 Dec 2025
Net transactions value: -$319,798
Form type: 4
Filing time: 17 Dec 2025, 16:24:49 UTC
Previous filing: 10 Dec 2025
Next filing: 24 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hartley Lindsey Marie	CFO	13631 PROGRESS BLVD., SUITE 400, ALACHUA	/s/ Marc Began, as attorney-in-fact for Lindsey Hartley	17 Dec 2025	0002068693

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXGN	Common Stock	Options Exercise	$122,495	+14,812	+47%	$8.27	46,188	15 Dec 2025	Direct
transaction	AXGN	Common Stock	Sale	$442,294	-14,812	-32%	$29.86	31,376	15 Dec 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXGN	Employee Stock Option (right to purchase)	Options Exercise	$0	-14,812	-100%	$0.000000	0	15 Dec 2025	Common Stock	14,812	$8.27	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.875 to $29.860 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.

Content

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.875 to $29.860 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vested on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.